Scope, delivery and quality.
CTD is the globally recognized modular structure for pharmaceutical registration evidence. The five modules must preserve a clear relationship between clinical and nonclinical findings, quality documentation, product information, and region-specific administrative materials. The central challenge is not merely formatting thousands of pages but proving that summaries, data tables, labels, and source reports tell a consistent scientific story.
Dossier preparation does not authorize creation or alteration of missing clinical, analytical, or safety findings. Every number and claim must be traceable to approved source material owned or authorized by the client. Regulatory authorship and language editing must be distinguished in the scope and acceptance criteria.
Service components & deliverables
Map the content requirements of all five CTD modules
Output linkage: Indexed CTD content map. Quality check: Critical data points traced back to source.
Localize Module 1 to market-specific requirements
Output linkage: Module-by-module missing-document register. Quality check: Cross-module review checklist.
Review Module 2 Quality Overall Summary and overviews
Output linkage: Cross-module consistency and review report. Quality check: Source-to-claim evidence register.
Trace Module 3 CMC claims to primary records
Output linkage: Controlled bilingual dossier materials where required. Quality check: Controlled release and version freeze.
Review Module 4 nonclinical study documentation
Output linkage: Scientific source-to-claim traceability matrix. Quality check: Documented gap ownership and escalation.
Review Module 5 clinical summaries and reports
Output linkage: Ready-to-publish document package. Quality check: Product-specific terminology control.
Perform cross-module terminology and consistency checks
Output linkage: Indexed CTD content map. Quality check: Critical data points traced back to source.
Prepare content-related inquiries and response dossiers
Output linkage: Module-by-module missing-document register. Quality check: Cross-module review checklist.
Typical inputs and outputs
Existing dossier and approved source documents
Indexed CTD content map
SmPC, PIL, package labeling, and artwork
Module-by-module missing-document register
Method validation and stability study reports
Cross-module consistency and review report
Clinical study and bioequivalence reports
Controlled bilingual dossier materials where required
CPP, GMP certificates, and legal mandates
Scientific source-to-claim traceability matrix
Region-specific naming and content rules
Ready-to-publish document package
Illustrative delivery workflow
Inventory and version-control primary documents
Input: Existing dossier and approved source documents. Check: Critical data points traced back to source.
Map each required CTD heading to its source
Input: SmPC, PIL, package labeling, and artwork. Check: Cross-module review checklist.
Assign specialist review to each module
Input: Method validation and stability study reports. Check: Source-to-claim evidence register.
Cross-check summaries against underlying reports
Input: Clinical study and bioequivalence reports. Check: Controlled release and version freeze.
Resolve discrepancies through a tracked query process
Input: CPP, GMP certificates, and legal mandates. Check: Documented gap ownership and escalation.
Freeze approved versions for downstream publishing
Input: Region-specific naming and content rules. Check: Product-specific terminology control.
Quality and risk controls
Dose values disagreeing between label and study
Critical data points traced back to source
QOS claims inconsistent with Module 3
Cross-module review checklist
Scientific assertions without a source study
Source-to-claim evidence register
Outdated certificates or report versions
Controlled release and version freeze
Missing mandatory nonclinical or clinical data
Documented gap ownership and escalation
Terminological drift over extensive documentation
Product-specific terminology control

